What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...

As a reminder, the board made its decision to transition the Chief Executive Officer position following the announced sale of ...

Teleflex faces a complex transition after divesting major business units at low multiples, creating uncertainty around future ...

Teleflex (NYSE: TFX) reported its Q4 earnings results on Thursday, February 26, 2026 at 06:30 AM. Here's what investors need to know about the announcement. Teleflex missed estimated earnings by -48.4 ...

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, ...

Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 28.5% year on year to $569 million. Its non-GAAP profit of $1.93 per share was ...

Q4 2025 Management View Stuart Randle, CEO, Interim President & Director, highlighted the ongoing transformation following the announced sale of the Acute Care, Interventional Urology, and OEM ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

Teleflex TFX posted solid fourth-quarter performance, ending the year on a stable note. On one hand, currency was a major headwind across all segments this fiscal year, and supply chain and staffing ...

As of Thursday, February 26, Teleflex Incorporated’s TFX share price has surged by 7.09%, which has investors questioning if this is right time to sell.

Teleflex (NYSE: TFX) reported fourth quarter EPS of $1.93, $1.86 worse than the analyst estimate of $3.79. Revenue for the quarter came in at $568.98M versus the c ...